Previous close | 139.48 |
Open | 139.98 |
Bid | 138.62 x 300 |
Ask | 138.95 x 300 |
Day's range | 138.51 - 140.80 |
52-week range | 74.75 - 142.00 |
Volume | |
Avg. volume | 3,115,511 |
Market cap | 53.471B |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | 106.69 |
EPS (TTM) | 1.30 |
Earnings date | 25 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 149.14 |
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy underperformed the Russell Midcap Growth Index and returned 13.66% (gross) and 13.44% (net) while the index return was -14.55%. In addition, please check […]
Dexcom Stock: The diabetes play rallied to new highs this week, topping a new buy point in the wake of the FDA's clearance of a new device.
Investors are optimistic about DexCom's (DXCM) strong product portfolio.